lusaris therapeutics

Biotech startup launched with $60 million 10 months ago – now it’s gone

Posted by WRAL TechWire | Oct 3, 2023

Last December a biotechnology startup – set to be housed in Research Triangle Park – launched with $60 million in funding and the aim of finding an effective therapy for treatment-resistant depression and other debilitating neuropsychiatric disorders. Now, it’s gone.

$60M RTP startup aims to redefine treatment of severe neuropsychiatric, neurological disorders

Posted by WRAL TechWire | Dec 15, 2022

A biotechnology startup – soon to be housed in Research Triangle Park – has launched with $60 million in funding and the aim of finding an effective therapy for treatment-resistant depression and other debilitating neuropsychiatric disorders.